Package 76162-009-76

Brand: cetirizine hydrochloride

Generic: cetirizine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 76162-009-76
Digits Only 7616200976
Product NDC 76162-009
Description

4 BLISTER PACK in 1 CARTON (76162-009-76) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2024-06-06
Brand cetirizine hydrochloride
Generic cetirizine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7baa79c5-be46-4b09-8cae-c306edb7f97a", "openfda": {"unii": ["64O047KTOA"], "rxcui": ["1011482"], "spl_set_id": ["f4ba3e0c-e6b3-2596-e053-2a95a90ab850"], "manufacturer_name": ["TOPCO ASSOCIATES LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (76162-009-76)  / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "76162-009-76", "marketing_start_date": "20240606"}], "brand_name": "Cetirizine Hydrochloride", "product_id": "76162-009_7baa79c5-be46-4b09-8cae-c306edb7f97a", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "76162-009", "generic_name": "Cetirizine Hydrochloride", "labeler_name": "TOPCO ASSOCIATES LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Cetirizine Hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA213557", "marketing_category": "ANDA", "marketing_start_date": "20240606", "listing_expiration_date": "20261231"}